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Running title: NCAM regulates temporal NPC specification 26 
 27 
Summary 28 
The role of NCAM in corticogenesis is incompletely understood. The authors demonstrate 29 
that NCAM controls NPC proliferation and fate decision through profilin2-dependent 30 
regulation of actin polymerization. This finding sheds new light on NCAM’s functions in 31 
neurodevelopmental and mental disorders.  32 
 33 
Abstract  34 
The development of cerebral cortex requires spatially and temporally orchestrated 35 
proliferation, migration and differentiation of neural progenitor cells (NPCs). The molecular 36 
mechanisms underlying cortical development are, however, not fully understood. The neural 37 
cell adhesion molecule (NCAM) has been suggested to play a role in corticogenesis. Here we 38 
show that NCAM is dynamically expressed in the developing cortex. NCAM expression in 39 
NPCs is highest in the neurogenic period and declines during the gliogenic period. In mice 40 
bearing an NPC-specific NCAM deletion, proliferation of NPCs is reduced, and production of 41 
cortical neurons is delayed, while formation of cortical glia is advanced. Mechanistically, 42 
NCAM enhances actin polymerization in NPCs by interacting with actin-associated protein 43 
profilin2. NCAM-dependent regulation of NPCs is blocked by mutations in the profilin2 44 
binding site. Thus, NCAM plays an essential role in NPC proliferation and fate decision during 45 
cortical development by regulating profilin2-dependent actin polymerization. 46 
 47 
Keywords: NCAM, profilin2, cerebral cortex, neural progenitor cell, actin   48 
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Introduction  49 
The development of the mammalian cerebral cortex requires spatially and temporally 50 
orchestrated proliferation, migration, and differentiation of neural progenitor cells (NPCs) 51 
(Greig et al., 2013). Radial glial cells (RGCs) in the ventricular zone (VZ) contribute to the 52 
generation of cortical layers directly or indirectly through intermediate progenitor cells (IPCs) 53 
(Gal et al., 2006; Haubensak et al., 2004). Cortical neurons are generated in a defined temporal 54 
sequence, in which neurons in deeper layers are generated first. Following neurogenesis, 55 
astrocytes appear shortly before birth, whereas oligodendrocytes emerge postnatally in 56 
mammals (Kohwi and Doe, 2013). Both intrinsic and extrinsic factors contribute to this 57 
developmental sequence. In humans, disturbance of this highly elaborate process leads to 58 
neurodevelopmental defects ranging between devastating malformations and relatively mild 59 
abnormalities causing neurological diseases such as epilepsy, schizophrenia and autism 60 
spectrum disorders (Gaspard and Vanderhaeghen, 2011).  61 
The neural cell adhesion molecule (NCAM) is a membrane-bound cell recognition 62 
molecule of the immunoglobulin superfamily. NCAM contributes to the nervous system 63 
development by influencing neuronal migration, neurite outgrowth, synapse formation, and 64 
synaptic plasticity (Sytnyk et al., 2017). Alternative splicing of NCAM transcripts generates 65 
three major isoforms: NCAM180, -140, and -120. NCAM180 and NCAM140 are 66 
transmembrane isoforms bearing an intracellular domain, which is longer in NCAM180. 67 
NCAM120 is anchored to the membrane via a glycosylphosphatidylinositol linkage (Sytnyk et 68 
al., 2017). Soluble extracellular NCAM fragments can be produced by NCAM ectodomain 69 
shedding (Hubschmann et al., 2005; Secher, 2010). NCAM knockout mice display an abnormal 70 
brain structure as well as learning and behavioral abnormalities (Brandewiede et al., 2014; 71 
Bukalo et al., 2004; Stork et al., 1999; Wood et al., 1998). Moreover, single nucleotide 72 
polymorphisms in the NCAM gene and/or abnormal polysialylation or proteolysis of NCAM 73 
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protein alter NCAM function in neurodevelopmental, neuropsychiatric, and neurodegenerative 74 
disorders in humans (Brennaman and Maness, 2010; Hidese et al., 2017; Purcell et al., 2001; 75 
Wang et al., 2012), suggesting a crucial role of NCAM in cortical development.  76 
NCAM plays a role in regulation of neurogenesis. Recombinant soluble NCAM reduces 77 
hippocampal NPC proliferation by heterophilic binding to an unknown cell surface receptor 78 
(Amoureux et al., 2000; Shin et al., 2002). Soluble NCAM and overexpression of NCAM140 79 
in NPCs promote differentiation of NPCs into the neuronal lineage (Amoureux et al., 2000; 80 
Kim and Son, 2006; Kim et al., 2005; Klein et al., 2014), while ectopic expression of 81 
NCAM140 in RGCs increases cell proliferation in vivo (Boutin et al., 2009). However, it is 82 
unknown whether NCAM is an intrinsic modulator of NPC proliferation and differentiation.  83 
Regulation of the cell cycle plays a crucial role in controlling temporal and spatial 84 
production of neural cells (Dehay and Kennedy, 2007; Politis et al., 2008). Cell cycle 85 
progression is modulated by the actin cytoskeleton which regulates cell rounding and rigidity 86 
for proper positioning and spindle orientation during mitosis (Heng and Koh, 2010; Kunda and 87 
Baum, 2009). Actin cytoskeleton reorganization during mitosis is controlled by actin-binding 88 
proteins, among which profilins are essential for cytokinesis (Suetsugu et al., 1999). Profilins 89 
are a conserved family of small proteins that facilitate the addition of actin monomers to the 90 
fast growing end of actin filaments by accelerating the ADP-ATP nucleotide exchange (Witke, 91 
2004). Among the four profilin subtypes, profilin2 is most expressed in the central nervous 92 
system (Di Nardo et al., 2000) where it contributes to maintaining spine density and dendritic 93 
complexity (Michaelsen et al., 2010). Profilin2 also stabilizes spine structure, controls 94 
presynaptic vesicular exocytosis (Pilo Boyl et al., 2007), and is required for synaptic plasticity 95 
(Chakraborty et al., 2014). However, the role of profilins in cortical development is so far 96 
unknown.   97 
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Results 98 
NCAM is dynamically expressed in NPCs during cortical development 99 
We first examined the NCAM expression profile. NCAM levels, particularly of the 100 
NCAM180 and NCAM140 isoforms, steadily increased in the developing mouse cortex (Fig. 101 
S1A-F). To further analyze the expression of NCAM in distinct cell types, coronal cortical 102 
sections at different embryonic stages (embryonic day 12 (E12) to postnatal day 0 (P0)) were 103 
co-immunostained for NCAM and either Sox2 (NPCs) or Tuj1 (neurons), respectively. NCAM 104 
was expressed in both NPCs (Fig. 1A) and neurons (Fig. 1B) in the developing cortex. 105 
Quantification of NCAM immunofluorescence intensities revealed that NCAM was 106 
predominantly expressed by NPCs in the ventricular zone/subventricular zone (VZ/SVZ), and 107 
by neurons in the intermediate zone (IZ), cortical plate (CP), and marginal zone (MZ) during 108 
the early neurogenic period (E12 to E14). Interestingly, NCAM immunofluorescence intensity 109 
in VZ/SVZ in relation to that in the total dorsal brain (Fig. 1C) as well as average NCAM 110 
immunofluorescence density in VZ/SVZ (Fig. 1D) decreased from E16 onward reaching the 111 
lowest level at E18 and P0 (gliogenic period). In contrast, NCAM immunoreactivity did not 112 
change in the IZ and MZ and even increased in the CP at E18 and P0 compared to E16, 113 
indicating that NCAM levels are maintained during these developmental stages in areas 114 
enriched in cortical neurons. (Fig. 1A-D and Fig. S1H). These results indicate that NCAM is 115 
expressed in NPCs in the early neurogenic period, whereas NCAM expression in NPCs declines 116 
during the gliogenic period.  117 
 118 
NCAM deficiency results in transiently reduced NPC proliferation in the developing 119 
cerebral cortex 120 
We next examined the role of NCAM in NPCs by generating NCAM conditional knockout 121 
(cKO) mice via crossing NCAM-floxed mice with Nestin-cre mice to ablate NCAM expression 122 
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in NPCs. NCAM was not detectable in NPCs (Fig. S1H) and other brain cell populations (data 123 
not shown) in NCAM cKO mice. We then examined whether NPC pool was affected by NCAM 124 
deficiency. Numbers of Pax6+ RGCs were reduced in the VZ in NCAM cKO mice at E12 and 125 
E14, but not at E16 and E18 compared to control littermates (Fig. 2A, B). Numbers of Tbr2+ 126 
IPCs, which mainly localize in SVZ, were also decreased in NCAM cKO mice at E12, but not 127 
at E14 and E16 (Fig. 2E, F). These results indicate that NCAM deficiency leads to transient 128 
reduction of NPC numbers during cortical development.  129 
The total number of BrdU+ cells (Fig. 2C) and the percentage of proliferating 130 
Pax6+BrdU+/Pax6+ RGCs (Fig. 2D) were reduced in NCAM cKO mice compared to control 131 
littermates at E12 and E14, but not at E16 and E18, indicating that NCAM regulates RGC 132 
proliferation only during earlier developmental stages. Consistently, the numbers of Ki67+ (Fig. 133 
2G, H) or PH3+ (Fig. 2I, J) cells, representing cells in the cell cycle or in mitosis, were also 134 
decreased in E12 NCAM cKO mice. This finding suggests that NCAM deficiency results in 135 
fewer NPCs in the cell cycle and mitosis at this stage. The decreased proliferation of NCAM 136 
cKO NPCs was not due to enhanced apoptosis, as the numbers of cleaved active caspase3+ 137 
NPCs were similar in NCAM cKO and control littermates at E12, E14, and E16 (Fig. S2). 138 
We also analyzed whether NCAM deficiency affects cell cycle exit and length in the 139 
VZ/SVZ. The cell cycle exit index (proportion of BrdU+Ki67− cells in BrdU+ cell population) 140 
was increased at E14 in the VZ/SVZ of NCAM cKO mice compared to control littermates (Fig. 141 
2K, L). S-phase length, estimated by the proportion of BrdU+Ki67+ cells in the Ki67+ cell 142 
population, was not altered at E14 (Fig. 2K, M). These data indicate that NCAM deficiency 143 
results in enhanced cell cycle exit and decreased NPC proliferation, eventually reducing the 144 
NPC pool during early neurogenic period. 145 
 146 
NCAM deficiency delays the generation of cortical neurons 147 
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Next, we analyzed whether NCAM regulates the generation of layer-specific neurons at 148 
different embryonic stages. The numbers of Tbr1+ neurons in layer VI in NCAM cKO cortices 149 
were decreased at E12 and E14, increased at E16, and unaltered at E18 (Fig. 3A, D). Ctip2+ 150 
neuron numbers in layer V in NCAM cKO mice were decreased at E12 and E14, but unchanged 151 
at E16 (Fig. 3B, E). The numbers of Cux1+ neurons in layers II–IV in NCAM cKO mice were 152 
reduced at E16, E18 and P0, but returned to control levels at P7 (Fig. 3C, F). Spatial distribution 153 
of these cortical neurons was unaltered in NCAM cKO mice (Fig. S3), suggesting that the lower 154 
numbers of cortical neurons observed in NCAM cKO mice are not caused by a migration defect.  155 
Decreased numbers of both deep- and upper-layer cortical neurons at earlier developmental 156 
stages, but normal levels at later developmental stages can also be explained by a delayed 157 
generation of cortical neurons in NCAM deficient mice. To assess this possibility, we performed 158 
birth-dating analysis to examine the generation date of distinct cortical neurons. Pregnant mice 159 
were injected with BrdU at E11.5, E14.5, E15.5, or E16.5. The embryos were collected at either 160 
E18 (for analysis of Tbr1+ and Ctip2+ neuron generation) or P2 (for analysis of Cux1+ neuron 161 
generation). The proportion of cell-specific neurons born at the time of injection (BrdU+marker+ 162 
cells/total number of marker+ cells) was analyzed. Generation of Tbr1+ and Ctip2+ neurons was 163 
lower at E11.5 (Fig. 4A, B, D), but higher at E14.5 (Fig. 4A, B, E) in NCAM cKO mice. This 164 
inter-genotype difference diminished at E15.5 (Fig. 4A, B, F) when deep-layer neuron 165 
generation is close to completion. These data aligned well with our findings that the numbers 166 
of deep-layer neurons were reduced in NCAM cKO mice at E12 and E14, but were normal by 167 
E18 (Fig. 3D, E). The generation of upper-layer neurons (Cux1+BrdU+/Cux1+cells) was 168 
reduced at E16.5 in NCAM cKO mice (Fig. 4C, G), which could explain the decreased numbers 169 
of upper-layer neurons from E16 to P0 (Fig. 3F). The number of upper-layer neurons in NCAM 170 
cKO mice was normal at P7 (Fig. 3F), indicating a postnatal “rescue” generation of upper-layer 171 
8 
 
neurons. In summary, these data strongly indicate that NCAM regulates the temporal generation 172 
of cortical neurons.  173 
 174 
NCAM deficiency leads to precocious gliogenesis 175 
We further examined whether NCAM regulates the temporal generation of glial cells. More 176 
GFAP+ cells were observed in NCAM cKO mice than in control littermates at E18 and P0 (Fig. 177 
5A, B). Interestingly, GFAP+ cells were observed in the VZ/SVZ of NCAM cKO mice at E16 178 
(Fig. 5A, C) while fewer GFAP+ cells were observed in control brains at this stage because 179 
astrocytes normally do not appear before E18 (Miller and Gauthier, 2007; Molofsky et al., 180 
2012). The result indicates an earlier appearance of astrocytes in NCAM cKO mice. The inter-181 
genotype difference diminished at P7, when astrocyte generation is close to completion (Wang 182 
and Bordey, 2008) (Fig. 5A, B). Birth-dating analysis of astrocytes by BrdU pulse-labeling at 183 
the onset of their generation at E16.5 (Miller and Gauthier, 2007) and calculating the numbers 184 
of BrdU+GFAP+ cells at P2 revealed more BrdU+GFAP+ cells in NCAM cKO mice (Fig. 5D, 185 
E), indicating an increased generation of astrocytes at E16.5 in NCAM cKO mice. Numbers of 186 
Olig2+ oligodendrocytes were increased in NCAM cKO brains at E18, but similar to those in 187 
control mice at P0 (Fig. 5F, G). Birth-dating analysis of oligodendrocytes by BrdU pulse-188 
labeling at E16.5 showed that the percentage of BrdU+Olig2+cells was increased in NCAM 189 
cKO mice at P2 (Fig. 5H, I). Consistent with these results, numbers of cells expressing brain 190 
lipid binding protein (BLBP) (Fig. 5L, M), which is initially expressed in RGCs and later 191 
becomes restricted to astrocytes (Feng et al., 1994; Kurtz et al., 1994), as well as numbers of 192 
cells expressing A2B5, a marker of immature glial restricted progenitors (Baracskay et al., 193 
2007; Dietrich et al., 2002) (Fig. 5J, K), were increased in the brains of NCAM cKO mice at 194 
E14 and E16, respectively. This increase was not due to an expansion of the RGC pool since 195 
the numbers of Pax6+ RGCs were reduced at E14 and reached normal levels at E16 (Fig. 2A, 196 
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B). Thus, the increase in numbers of BLBP+ and A2B5+ cells is likely due to an enhanced glial 197 
progenitor density, reflecting an earlier glial specification. Taken together, these results suggest 198 
that NCAM deficiency in NPCs results in precocious gliogenesis. 199 
 200 
Profilin2 binds to NCAM 201 
To investigate the molecular mechanisms underlying NCAM-dependent cortical 202 
development, yeast two-hybrid screening was performed with NCAM140 as a bait (Li et al., 203 
2013). NCAM140 in NPCs is expressed at higher levels relative to other isoforms 204 
(Prodromidou et al., 2014). Among >2x106 clones screened, 26 clones were positive. A BLAST 205 
database search (http://www.ncbi.nlm.nih.gov/BLAST/) indicated that one clone, encoding full 206 
length profilin2, was in the correct open reading frame. To confirm the association between 207 
NCAM and profilin2, NCAM was immunoprecipitated from neonatal brain homogenates using 208 
polyclonal antibodies recognizing NCAM extracellular domain. Western blot analysis showed 209 
that profilin2 was co-immunoprecipitated by NCAM antibodies. Inversely, NCAM120, 210 
NCAM140, NCAM180, and soluble NCAM105 were co-immunoprecipitated by profilin2 211 
antibodies (Fig. 6A). Direct binding was assessed by ELISA, with profilin2 being substrate-212 
coated and probed by the recombinantly expressed intracellular domains of NCAM140 and 213 
NCAM180. NCAM140, but notably not NCAM180, bound to profilin2 in a concentration-214 
dependent and saturable manner (Fig. 6B). Identification of profilin2-binding sites in NCAM 215 
revealed that peptides encoding aa729-750 and aa748-763 bound to profilin2 (Fig. 6C). These 216 
two peptides had three overlapping amino acids: asparagine (N748), leucine (L749), and cysteine 217 
(C750). To investigate whether these amino acids mediated the binding to profilin2, binding of 218 
profilin2 to a non-mutated 745IAVNLCGKA753 peptide comprising the NLC motif and two 219 
mutated peptides (with two of these three amino acids changed at a time) was analyzed. 220 
Mutation of L749 and C750 into alanine (A749) and serine (S750) completely blocked the binding 221 
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to profilin2 (Fig. 6D). Mutation of N748 and L749 into glutamine (Q748) and alanine (A749) 222 
partially suppressed the interaction, suggesting that N748 is not crucial for it (Fig. 6D). Mutation 223 
of 749LC750 in the recombinant intracellular domain of NCAM140 to 749AS750 also abolished its 224 
binding to profilin2 as tested by ELISA, confirming that L749 and C750 are essential for the 225 
binding of NCAM140 to profilin2 (Fig. 6E, F). 226 
 227 
Profilin2 exhibits an expression pattern similar to that of NCAM in the developing cortex  228 
To analyze whether NCAM co-localizes with profilin2 in the developing cortex, cortical 229 
sections of E12-P0 wild type mice were co-immunostained for NCAM, profilin2, and Sox2 230 
(Fig. 6G), or Tuj1 (Fig. 6H). Profilin2 co-localized with NCAM at all developmental stages 231 
analyzed exhibiting an expression pattern similar to that of NCAM (Fig. 6I, J, S5B). Although 232 
profilin2 levels increased in the whole brain during development (Fig. S1A, G), both the 233 
average profilin2 immunofluorescence density in VZ/SVZ (Fig. 6I) as well as the percentage 234 
of profilin2 immunofluorescence intensity in VZ/SVZ to that in the total dorsal brain (Fig. 6J) 235 
decreased. This was particularly evident in the gliogenic period. Profilin2 protein (Fig. 6K, L) 236 
and mRNA (Fig. 6M) expression were reduced in NCAM cKO versus wild type NPCs, 237 
suggesting that NCAM regulates profilin2 expression and further implying the functional 238 
relationship between these two proteins.  239 
 240 
Profilin2 is required for NCAM-dependent NPC proliferation and differentiation 241 
To explore whether NCAM controls the proliferation of NPCs through profilin2, BrdU 242 
incorporation was analyzed in cultured NPCs transfected with either profilin2 siRNA 243 
(siProfilin2) or control (scrambled) siRNA (NC). NPCs were analyzed after incubation with or 244 
without NCAM antibodies recognizing NCAM extracellular domain and triggering 245 
downstream signaling of NCAM (Li et al., 2013). Transfection of siProfilin2 suppressed 246 
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profilin2 (Fig. S4A, B, C), but not profilin1 expression (Fig. S4D) in Neuro-2a cells and NPCs, 247 
and decreased NPC proliferation (Fig. 7A, C; siprofilin2-399). Incubation with NCAM 248 
antibodies increased proliferation of NPCs transfected with control siRNA, but not of NPCs 249 
transfected with siProfilin2 (Fig. 7A, C). This indicates that NCAM promotes the proliferation 250 
of NPCs through profilin2.  251 
To investigate whether profilin2 plays a role in NCAM-dependent differentiation of NPCs, 252 
NC- or siProfilin2 (siProfilin2-399)-transfected NPCs were allowed to differentiate in the 253 
absence or presence of NCAM antibodies for 5 days. Immunofluorescence analysis showed 254 
that the percentages of Tuj1+ cells (Fig. 7B, D) were decreased, whereas the percentages of 255 
GFAP+ (Fig. 7E, G) and O4+ cells (Fig. 7F, H) were increased by profilin2 knockdown. These 256 
observations indicate that profilin2, similar to NCAM, promotes neuronal differentiation and 257 
suppresses differentiation of NPCs into glial cells. Consistent with in-vivo results, NCAM 258 
antibody treatment increased the percentages of Tuj1+ cells (Fig. 7B, D) but decreased GFAP+ 259 
(Fig. 7E, G) and O4+ cell percentages (Fig. 7F, H) in NC-transfected NPCs. However, the effect 260 
of NCAM antibodies on neuronal and astroglial differentiation was abolished in NPCs 261 
transfected with siProfilin2 (Fig. 7B, D, E, G), indicating that profilin2 is required for NCAM-262 
dependent regulation of neuronal and astroglial differentiation. Profilin2 knockdown reduced, 263 
but did not abolish the suppressing effect of NCAM antibodies on oligodendroglial 264 
differentiation (Fig. 7F, H). To further confirm that profilin2 is involved in NCAM-regulated 265 
NPC differentiation in a cell autonomous manner, NPCs were transfected with shRNA Profilin2 266 
(shProfilin2) alone or together with shRNA-resistant profilin2 plasmids encoding GFP under a 267 
separate promotor. NPCs were then treated with NCAM antibodies. NCAM antibody-enhanced 268 
neurogenesis and -decreased astrogenesis were prevented by profilin2 knockdown, which was 269 
rescued by cotransfection with shRNA-resistant profilin2 (Fig. 7I-K). Therefore, these results 270 
indicate that profilin2 is the downstream effector of NCAM, through which NCAM regulates 271 
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NPC proliferation and differentiation.  272 
 273 
NCAM regulates actin cytoskeleton dynamics through profilin2 274 
We further tested whether NCAM regulates NPC proliferation and differentiation through 275 
profilin2-mediated actin polymerization. Western blot analysis of total cell lysates showed that 276 
the expression of actin did not differ between control and NCAM cKO NPCs. However, the 277 
depolymerized actin (G-actin) levels were higher in NCAM cKO NPCs. Proportionally, the 278 
polymerized actin (F-actin) levels were reduced in NCAM cKO NPCs (Fig. 8A, B), indicating 279 
that NCAM promotes actin polymerization. Western blot analysis revealed that NCAM 280 
knockdown-induced reduction of the F-/G-actin ratio was rescued by wild type NCAM140, but 281 
not mutNCAM (unable to bind profilin2) in mouse embryonic fibroblasts (Fig. 8C). To confirm 282 
these data, control and NCAM cKO NPCs expressing GFP only, co-expressing wild type 283 
NCAM140, or mutNCAM were stained by fluorescent phalloidin and deoxyribonuclease I to 284 
visualize F- and G-actin, respectively. Fluorescent microscopy analysis showed that the F-/G-285 
actin ratio was reduced in NCAM cKO NPCs. Lentiviral transduction with wild type 286 
NCAM140, but not mutNCAM, increased the F-/G-actin ratio in NCAM cKO NPCs to control 287 
levels (Fig. 8D, E). The decreased F-/G-actin ratio in NCAM cKO NPCs was also rescued by 288 
profilin2 overexpression (Fig. 8F, G). These results indicate that NCAM promotes actin 289 
polymerization through its binding to profilin2.  290 
Actin cytoskeleton is crucial for soma rounding, and for increased rigidity during cell 291 
division (Kunda and Baum, 2009). The role of NCAM in cell shape alteration was investigated 292 
in dividing cells, and the cell shape index (CSI) of NPCs was calculated in meta- and anaphase 293 
at the VZ surface. NCAM deficiency leads to elongated morphology of NPCs and reduced CSI 294 
values (Fig. 8H, I), indicating that mitotic NPCs in NCAM cKO mice fail to round up, what is 295 
believed to lead to the perturbation of cell cycle progression (Heng and Koh, 2010).  296 
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Immunofluorescence analysis showed reduced NPC proliferation and neurogenesis, and 297 
increased astrogenesis in NCAM cKO NPCs (Fig. 8J-N). Transduction of NCAM cKO NPCs 298 
with wild type NCAM140, but not mutNCAM-expressing lentiviruses, normalized 299 
proliferation, neurogenesis and astrogenesis (Fig. 8J-N). Hence, NCAM controls the 300 
proliferation and differentiation of NPCs through binding to profilin2 via regulation of actin 301 
cytoskeleton dynamics.  302 
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Discussion 303 
We demonstrated that NCAM is dynamically expressed in the developing cortex with high 304 
expression in NPCs during the neurogenic period and lower expression in NPCs in the gliogenic 305 
period. Expression of NCAM is required for maintenance of the precise proliferation and the 306 
timely generation of cortical neurons and glial cells. Furthermore, profilin2 was identified to be 307 
the mediator of NCAM-dependent regulation of cytoskeleton dynamics controlling NPC 308 
proliferation and differentiation during cortical development (Fig. 9). 309 
Previous studies suggested that NCAM can function as both a cell-extrinsic and cell-310 
intrinsic signaling molecule in NPCs (Amoureux et al., 2000; Boutin et al., 2009; Kim and Son, 311 
2006; Klein et al., 2014; Prodromidou et al., 2014). The present study confirms these views by 312 
showing that specific ablation of NCAM expression in NPCs suppressed proliferation and 313 
enhanced cell cycle exit of NPCs at the earlier neurogenic stage, leading to a transiently reduced 314 
NPC pool. At later developmental stages, i.e. from E16 onwards, neither proliferation of NPCs 315 
nor NPC numbers in NCAM mutant mice were different from that in wild type mice. 316 
Interestingly, NCAM expression in NPCs was reduced from E16 onward, showing considerably 317 
reduced levels at the gliogenic period. Thus, the loss of NCAM-dependent regulation of NPC 318 
proliferation at later developmental stages may be due to the decline in NCAM expression. 319 
However, the fact that the transiently decreased proliferation in the earlier neurogenic period 320 
does not lead to an ultimately depleted NPC pool at later developmental stages also suggests a 321 
compensatory mechanism.  322 
During brain development, a number of cell cycle regulators are involved in cell fate 323 
specification while key factors for cell fate specification influence cell cycle (Politis et al., 324 
2008). In line with this notion, we observed a delayed generation of both upper- and deep-layer 325 
cortical neurons and a precocious gliogenesis in NCAM mutant mice. Furthermore, the 326 
transiently increased cell cycle exit upon NCAM deletion is paralleled by increased numbers 327 
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of glial progenitors during the neurogenic period, suggesting that cells exiting the cell cycle at 328 
E14 may adopt a glial fate. Consistently, GFAP+ astrocytes were observed in NCAM cKO 329 
brains as early as E16, despite the fact that astrocytes normally do not appear in rodent brains 330 
until E18 (Miller and Gauthier, 2007). Hence, it is likely that precocious astrogenesis is due to 331 
depletion of NCAM in NPCs at early rather than later development stages when NCAM 332 
expression in NPCs decreases. Gliogenesis is suppressed during the neurogenic period, and 333 
induced after neurons had been generated in sufficient numbers (Sloan and Barres, 2014). 334 
However, NCAM cKO mice exhibit a delayed neurogenesis. Thus, it is unlikely that the 335 
precocious astrogliogenesis observed in NCAM cKO mice is due to the delayed generation of 336 
neurons. Moreover, transfection of plasmids encoding NCAM decreased astrogliogenesis from 337 
cultured NCAM cKO NPCs, further confirming a cell-autonomous mechanism. Thus, we 338 
propose that NCAM, which is highly expressed in NPCs during the neurogenic period, 339 
promotes neurogenesis and suppresses gliogenesis (Fig. 9).  340 
We provide evidence that NCAM regulates the proliferation and differentiation of NPCs 341 
via its binding to profilin2, which interacts directly with NCAM140 intracellular domain. 342 
NCAM180, NCAM120 and the soluble extracellular domain of NCAM also co-343 
immunoprecipitate with profilin2, most likely due to their homophilic binding to NCAM140 344 
(Soroka et al., 2003). Surprisingly, NCAM180 does not bind directly to profilin2 although 345 
NCAM140 and NCAM180 comprise overlapping amino acid sequences in their intracellular 346 
domains, suggesting that NCAM180 is conformationally restricted from its interaction with 347 
profilin2. NCAM180 accumulates at contacts between cells, and a reduction in its association 348 
with the actin filament-remodeling proteins may be important for stabilization of cell contacts 349 
(Pollerberg et al., 1986). In contrast, NCAM140 is more involved in dynamic cell interactions. 350 
NCAM120 and NCAM140 are the predominant forms of NCAM in NPCs at E14 (Fig. 6K and 351 
(Prodromidou et al., 2014) whereas NCAM180 and NCAM140 are the major isoforms in 352 
16 
 
neurons (Korshunova et al., 2007). Consistently, NCAM140, but not its mutant with abolished 353 
binding to profilin2, rescues abnormal proliferation and differentiation of NPCs caused by 354 
NCAM depletion in NPCs. Thus, the combined observations suggest that NCAM-dependent 355 
regulation of neuronal development is fine-tuned by the temporally specific expression patterns 356 
of NCAM isoforms.  357 
Regulation of actin dynamics by profilin1 and -2 require both discrete and cooperative 358 
activities. One example is that expression of profilin1 rescues the loss of spines (but not 359 
dendritic complexity) caused by profilin2 knockdown (Michaelsen et al., 2010). Indeed, 360 
profilin2-deficient neurons show an initial, transient increase in the number of sprouting 361 
neurites, which may be due to the compensatory function of profilin1 (Da Silva et al., 2003). 362 
In addition, NCAM-depleted NPCs exhibit reduced profilin2 levels. Thus, the transient nature 363 
of abnormalities in NPCs observed in NCAM cKO cells may be due to a functional 364 
compensation by profilin1. We herein show that profilin2 is required for NCAM-regulated NPC 365 
proliferation and differentiation, which depends on binding of NCAM to profilin2 which 366 
exhibits an expression profile similar to that of NCAM in NPCs during brain development. 367 
Acute profilin2 knockdown in cultured NPCs results in a phenotype being comparable to that 368 
of NCAM-deficient NPCs, suggesting that profilin2 and NCAM have similar roles in the 369 
developing cerebral cortex. Consistently, profilin2-deficient mice are hyperactive and show 370 
increased exploratory behavior (Pilo Boyl et al., 2007), thus partly resembling behavioral 371 
abnormalities in NCAM-deficient mice. Profilins bind to various ligands and are involved in 372 
distinct cellular processes, such as membrane and vesicle trafficking, endocytosis, and receptor 373 
clustering. Profilins are also found in the cell nucleus, where they may be involved in chromatin 374 
remodeling and transcription (Witke, 2004). Further research is required for a more holistic 375 
understanding of the role of profilin2 during cortical development.  376 
NCAM is the major carrier of the linear homopolymer α2-8-N acetylneuraminic acid 377 
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(PSA), which plays a prominent role in regulation of migration and differentiation of progenitor 378 
cells during postnatal brain development (Angata et al., 2007), as well as in the adult brain 379 
(Burgess et al., 2008). We did not detect NCAM-PSA in E14 NPCs (Fig. 6K), which is in 380 
accordance with previous reports showing that NCAM is not polysialylated during the early 381 
phases of neurogenesis in the developing brain (Bonfanti, 2006; Prodromidou et al., 2014; Seki 382 
and Arai, 1991). This in turn suggests that NCAM rather than PSA plays a key role at these 383 
early development stages.  384 
Our observations also indicate that NCAM regulates corticogenesis by modulating actin 385 
dynamics. NCAM deficiency leads to reduced actin polymerization, elongated progenitor cell 386 
shape, and decreased mitosis (Fig. 9). Remodeling of the actin cytoskeleton during mitosis is 387 
necessary for formation of rounded cells with increased cortical rigidity (Heng and Koh, 2010; 388 
Luxenburg et al., 2011). At the end of mitosis, actin rearranges at cleavage furrows and 389 
contributes to formation of the contractile ring, which is crucial for cytokinesis. Another mitotic 390 
event requiring actin dynamics is centrosome separation, which depends on the flow of 391 
submembrane actin and the myosin network (Heng and Koh, 2010). The modulation of cell 392 
shape changes in coordination with cell cycle progression is a pre-requisite for the acquisition 393 
of appropriate cell fates and the transformation of proliferating, undifferentiated progenitors 394 
into fully differentiated, functional cells (Cremisi et al., 2003). We show that NCAM-dependent 395 
actin remodeling promotes neurogenesis, but suppresses gliogenesis. 396 
The actin cytoskeleton is also involved in transcription control (Miralles and Visa, 2006). 397 
Actin is a component of the transcription apparatus, chromatin-remodeling complexes, and 398 
RNA-processing machinery (Miralles and Visa, 2006). Our data show that deficiency in NCAM 399 
results in inhibited neurogenesis and enhanced gliogenesis from NPCs, suggesting a role for 400 
NCAM in the control of the neurogenic-gliogenic switch. This cell fate programming comprises 401 
specific signaling pathways, such as JAK-STAT, Notch, BMP, and MEK-ERK-dependent 402 
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signaling to activate transcription factors (Miller and Gauthier, 2007). Whether NCAM 403 
regulates transcription by modulating actin dynamics is a question for future investigation.  404 
In the developing brain, neurons are generated first, while gliogenesis is suppressed during 405 
the neurogenic period. Astrogliogenesis is induced later, after neurons had been generated in 406 
sufficient numbers (Sloan and Barres, 2014). Astrocytes, in turn, guide appropriate neurite and 407 
synapse development (Jacobs and Doering, 2010; Sloan and Barres, 2014). This temporal 408 
sequence of coordinated generation of neurons and astrocytes is required for proper 409 
establishment of neural circuits. Perturbations in the temporally orchestrated generation of 410 
neurons and glia may cause impaired neuronal development and synaptic plasticity, leading to 411 
neurodevelopmental disorders, such as Down syndrome, autism spectrum disorders and 412 
“RASopathies” (Jacobs and Doering, 2010; Sloan and Barres, 2014; Zdaniuk et al., 2011), the 413 
latter including Noonan (Tartaglia et al., 2001), neurofibromatosis-1 (Hegedus et al., 2007), 414 
costello (Paquin et al., 2009), and cardiofaciocutaneous syndrome (Urosevic et al., 2011). 415 
Despite a broad spectrum of clinical manifestations, these syndromes share some degree of 416 
mental impairment and precocious astrogenesis (Sloan and Barres, 2014). In turn, NCAM-417 
deficient mice display hyperactivity, increased aggression, learning deficits, and impaired nest 418 
building behaviors (Cremer et al., 1994; Stork et al., 1997; Stork et al., 2000; Stork et al., 1999; 419 
Vicente et al., 1997). 420 
In the mature brain, NCAM is involved in regulation of the number, structure, and 421 
molecular composition of synapses, synaptic vesicle recycling, synaptic plasticity, learning 422 
(Bukalo et al., 2004; Puchkov et al., 2011; Shetty et al., 2013; Sytnyk et al., 2006), and behavior 423 
(Brandewiede et al., 2014; Kohl et al., 2013; Pillai-Nair et al., 2005; Stork et al., 1999). By 424 
regulating actin polymerization (Schluter et al., 1997), profilin2 also plays a role in modulation 425 
of synaptic vesicle exocytosis, neuronal excitability (Pilo Boyl et al., 2007), spine density, 426 
dendritic complexity (Da Silva et al., 2003; Michaelsen et al., 2010; Witke et al., 1998), 427 
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learning, and memory consolidation (Lamprecht et al., 2006). Whether NCAM and profilin2 428 
co-operate in regulation of synapse formation and function is, however, unknown and remains 429 
a question for further investigation. 430 
Our study suggests that abnormalities in temporal NPC fate decision can contribute to the 431 
pathophysiology of neurodevelopmental diseases associated with abnormal function of NCAM. 432 
Understanding the molecular mechanisms underlying these abnormalities may help to design 433 
future strategies aimed at correcting neural differentiation in the affected brain.    434 
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Materials and methods 435 
Antibodies 436 
The following antibodies were used for immunofluorescence analysis: goat anti-Sox2 437 
(1:150, Santa Cruz Biotechnology, sc-17320, RRID: AB_2286684), mouse anti-BrdU (1:300, 438 
Covance, MMS-139S, RRID: AB_10719257), mouse anti-βIII-tubulin (1:500, Tuj1, Sigma-439 
Aldrich, T5076, RRID: AB_532291), mouse anti-profilin2 (1:100, Proteintech, 60094-2-Ig, 440 
RRID: AB_2163215), rabbit anti-NCAM (1:300, Alomone, ANR-041, RRID: AB_2756690), 441 
rabbit anti-NCAM (1:200, Thermo, 701379, RRID: AB_2532477), rabbit anti-Pax6 (1:300, 442 
Covance, PRB-278P, RRID: AB_291612), rabbit anti-Tbr1 (1:300, Abcam, ab3190, RRID: 443 
AB_2238610), rabbit anti-Tbr2 (1:300, Abcam, ab23345, RRID: AB_778267), rabbit anti-444 
Olig2 (1:300, Abcam, ab109186, RRID: AB_10861310), rabbit anti-GFAP (1:500, Millipore, 445 
MAB360, RRID: AB_11212597), rabbit anti-PH3 (1:300, Millipore, 06-570, RRID: 446 
AB_310177), rabbit anti-Ki67 (1:100, Thermo, PA5-19462, RRID: AB_10981523), rabbit anti-447 
Ctip2 (1:300, Abcam, ab28448, RRID: AB_1140055), rabbit anti-Cux1 (1:100, Santa Cruz 448 
Biotechnology, sc-13024, RRID: AB_2261231), rabbit anti-BLBP (1:100, Abcam, ab32423, 449 
RRID: AB_880078), mouse anti-A2B5 (1:300, Thermo, MA1-90445, RRID: AB_1954783) 450 
and rabbit anti-cleaved caspase3 (1:300, Cell Signaling, 9661, RRID: AB_2341188). Rabbit 451 
anti-NCAM (Alomone, ANR-041, RRID: AB_2756690) and rabbit anti-profilin2 (Abcam, 452 
ab174322, RRID: AB_2783646) antibodies were used for immunoprecipitation and Western 453 
blot analysis. Chicken anti-NCAM antibody (Li et al., 2013) was used to assay NPC 454 
proliferation and differentiation. Rat anti-NCAM (BD Pharmingen, 556323, RRID: 455 
AB_396361) antibody was used for Western blot analysis and ELISA. Mouse anti-actin 456 
(Sigma-Aldrich, A5441, RRID: AB_476744) antibody was used for immunofluorescence and 457 
Western blot analysis. Mouse anti-γ-tubulin antibody (Sigma-Aldrich, T6557, RRID: 458 
AB_477584) was used for Western blot analysis. Non-immune mouse immunoglobulin (IgG) 459 
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and horseradish peroxidase (HRP)-coupled secondary antibodies were purchased from Sigma-460 
Aldrich. Secondary antibodies conjugated with Alexa fluorophores 488, 555 or 647 were 461 
purchased from Invitrogen. Acti-stain™ 670 Fluorescent phalloidin (Cytoskeleton, PHDN1-A) 462 
was used for F-actin staining. Alexa Fluor 594 conjugated deoxyribonuclease I (Molecular 463 
Probes, D12372) was used for G-actin staining.  464 
 465 
Mice 466 
Homozygous NCAM-floxed mice (NCAMff+/+; (Bukalo et al., 2004) were crossed with 467 
Nestin-cre transgenic mice (Jackson Laboratory, 003771) to generate conditionally NCAM-468 
deficient (NCAMff+/+cre+/-, NCAM cKO) mice and their control littermates (referred to as 469 
NCAMff+/+cre-/- or NCAMff+/-cre-/-). Successful mating was verified by the presence of a 470 
vaginal plug. Observation date of the plug was considered E0.5. Mice had been backcrossed 471 
with C57BL/6J mice for more than 10 generations and were maintained on the C57BL/6J 472 
background thereafter. All experimental procedures were in accordance with ARRIVE (Animal 473 
Research: Reporting of In Vivo Experiments) guidelines and were approved by the Institutional 474 
Animal Care and Use Committee of Soochow University. 475 
 476 
DNA constructs, protein expression and ELISA  477 
Sequences of the intracellular domain of rat NCAM140 (NCAM140ICD) and NCAM180 478 
(NCAM180ICD) were subcloned from prokaryotic expression pQE30-NCAM140ICD and 479 
pQE30-NCAM180ICD plasmids (Li et al., 2013) into pET29b-His vector (Novagen, 69872). 480 
The pET29b-NCAM140ICD was used as a template to produce the mutant NCAM140ICD 481 
expression vector, pET29b-muNCAM140ICD, by site-directed mutagenesis with CTG 482 
encoding L749 mutated into GCG, and TGT encoding C750 mutated into TCT. Primers for 483 
mutagenesis were TGCATCGCTGTTAACGCGTCTGGCAAAGCTGGG (forward), and 484 
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CATGAGCAGGCCACACTTGTTCAGGAAGTAGCAGG (reverse). The pET29b-profilin2 485 
was synthesized by Takara (Dalian, China). The profilin2 sequence was subcloned into a 486 
pCDH-EF1-MCS-T2A-copGFP vector. The pEX4-siRNA-resistant-profilin2 plasmid was 487 
generated by Genepharma (Shanghai, China) using the pEX4-profilin2 as a template for three 488 
synonymous mutations on the profilin2 siRNA recognition sequence with 489 
CATCACGCCAGTAGAAATA mutated into CATTACTCCAGTTGAAATA. All plasmid 490 
constructs were verified by sequencing. Prokaryotic pET29b-NCAM140ICD, pET29b-491 
muNCAM140ICD, pET29b-NCAM180ICD, and pET29b-profilin2 plasmids were transformed 492 
and expressed in E. coli strain BL21, and corresponding recombinant proteins were purified by 493 
Ni-NTA chromatography (Qiagen, 30210).  494 
Profilin2 (100 μg/ml) was immobilized overnight at 4°C on a polyvinylchloride surface in 495 
96-well ELISA plates (Corning, 2595). Then, the wells were washed three times with PBST 496 
(PBS with 0.1% Tween 20, pH 7.4) and blocked with 3% BSA in carbonate buffer (35 mM 497 
NaHCO3 and 15 mM Na2CO3, pH 9.6) at 37°C for 2 h. Thereafter, increasing concentrations 498 
(0.1-12.5 µM) of recombinant NCAM140ICD, NCAM180ICD or muNCAM140ICD (in 499 
PBST) were applied at 37°C for 2 h. After three washes, the wells were incubated with NCAM 500 
monoclonal antibodies (0.5 μg/ml) for 1.5 h at 37°C. Following five washes with PBST, HRP-501 
conjugated secondary antibodies were applied for 1 h at 37°C. After five washes, protein 502 
binding was analyzed by adding the HRP substrate, tetramethylbenzidine reagent (Pierce, 503 
34021). The reaction was terminated with 2 M H2SO4 and ODs were measured at 450 nm using 504 
a plate reader (Thermo, 51119000). Biotinylated peptides comprising amino acid sequences 505 
729-750, 748-763, 756-770, 764-777, 766-810 of mouse NCAM140, 745IAV NLC GKA753 506 
peptide comprising the profilin2 binding site, and mutated 745IAV NAS GKA753 and 745IAV 507 
QAC GKA753 peptides were synthesized by SciLight Peptide (Beijing, China). All constructs 508 
were incubated with substrate-coated profilin2 and detected by HRP-coupled NeutrAvidin 509 
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(Thermo, 31030).  510 
 511 
RNA interference 512 
The siProfilin2-399 (CAUCACGCCAGUAGAAAUATT), siProfilin2-527 513 
(CAAUGGACAUCCGGACAAATT), siNCAM (GUUGGAGAGUCCAAAUUCUTT) and 514 
the NC (UUCUCCGAACGUGUCACGUTT) were synthesized by Genepharma (Shanghai, 515 
China). The shProfilin2 was constructed by Genechem (Shanghai, China) by inserting the same 516 
target sequence as siProfilin2-399 into the GV102 vector. To confirm siProfilin2 efficacy, 517 
Neuro-2a cells (ATCC, CCL-131™) were transfected with siRNA/shRNA using Lipofectamine 518 
2000 according to the manufacturer’s instructions (Invitrogen, 11668030). Mouse embryonic 519 
fibroblasts (MEFs, ATCC, SCRC-1008™) were transfected with siRNA using Lipofectamine 520 
2000. The profilin2/NCAM knockdown efficacy was verified by Western blot analysis of cell 521 
lysates. Cultured NPCs were transfected with 20 pmol of RNA per cuvette using the Amaxa® 522 
Nucleofector system (Lonza, VPG-1004) according to the user’s manual. 523 
 524 
Culture and transfection of NPCs  525 
NPCs were obtained from the telencephalic lateral ventricle walls of E14 embryos and 526 
cultured in DMEM/F12 culture medium (Gibco, 11320033) supplemented with 2% B27 527 
(Gibco, 17504044), 20 ng/ml basic fibroblast growth factor (bFGF, Peprotech, 96-450-33), and 528 
20 ng/ml epidermal growth factor (EGF, Peprotech, 315-09) as described (Ma et al., 2008). For 529 
differentiation, NPCs were cultured in DMEM/F12 medium containing 2% B27 and 0.5% fetal 530 
calf serum (Gibco) without EGF and bFGF for 5-7 days.  531 
For NCAM antibody incubation experiments, NCAM antibodies (10 µg/ml) were added 532 
to the culture medium and replenished every 24 h. The medium was changed every 48 h.  533 
Transfection of cultured NPCs was performed using the Amaxa® Nucleofector system 534 
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(Lonza, VPG-1004) according to the user’s manual. 535 
 536 
Lentiviral transduction 537 
Lentivirus constructs containing full-length wild type or mutated mouse NCAM140 genes 538 
were generated by Genechem (Shanghai, China) in an Ubi-MCS-3FLAG-SV40-EGFP-IRES-539 
puromycin (GV358) vector comprising ubiquitin, SV40, and CMV promoters. Cultured NPCs 540 
and MEFs were transduced with 1 x 108 TU/ml lentivirus following the manufacturer’s 541 
instructions and thereafter maintained for 2-4 d. 542 
 543 
BrdU labeling 544 
For analysis of proliferation in vivo, pregnant mice were intraperitoneally injected with 545 
BrdU (50 mg/kg, Sigma-Aldrich, B5002) at different embryonic stages (E12, E14, E16 and 546 
E18) and sacrificed 30 min thereafter (Wu et al., 2017). For determination of the cell cycle exit, 547 
BrdU (100 mg/kg) was intraperitoneally injected into pregnant mice, and mice were sacrificed 548 
18 h after injection. The cell cycle exit index was calculated as BrdU+Ki67-/total BrdU+ cells 549 
(the percentage of cells exiting the cell cycle). The length of S-phase of the cell cycle was 550 
calculated as BrdU+Ki67+/total Ki67+ cells.  551 
 For pulse-chase labeling of newborn cells, pregnant mice were intraperitoneally injected 552 
with BrdU (100 mg/kg) at E11.5, E14.5, E15.5 and sacrificed at E18, or injected with BrdU at 553 
E16.5 and sacrificed at P2. Quantification of birth-dated neurons was performed by calculating 554 
the percentages of BrdU+ layer-specific neuronal marker+ cells/total layer-specific neuronal 555 
marker+ (Tbr1+, Ctip2+ or Cux1+) cells. Quantitation of birth-dated oligodendrocytes was 556 
performed by calculating the percentage of Olig2+BrdU+ cells/total Olig2+ cells. Quantification 557 
of birth-dated astrocytes was calculated as the numbers of GFAP+BrdU+ cells along the 558 
dorsolateral VZ.  559 
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 To investigate NPC proliferation in vitro, cells were cultured for 4-5 h in NPC culture 560 
medium supplemented with 10 μM BrdU.  561 
 562 
Immunohistochemistry and image analysis 563 
Immunohistochemistry was performed as described elsewhere (Wu et al., 2017). Briefly, 564 
pregnant mice were sacrificed and the fetuses were removed from the uterus. Fetal brains were 565 
fixed in 4% formaldehyde in PBS (pH 7.3) for 24 h at 4 °C followed by sequential dehydration 566 
using 15% and 30% sucrose in PBS. Coronal sections (14 µm thick) were sectioned with a 567 
cryostat (Leica CM1950), and washed 3 times with PBS before blocking in 10% donkey serum 568 
in 0.1% Triton X-100 in PBS for 1 h at room temperature. Primary antibodies were applied in 569 
the blocking solution for 16 h at 4°C, followed by 3 washes in PBS. Secondary antibodies were 570 
incubated in the blocking solution for 1 h at room temperature. Sections were then washed, air-571 
dried, and mounted using DAPI Fluoromount-G (Southern Biotech, 0100-20). Fluorescence 572 
images were acquired with a Carl Zeiss Microscope Axio Scope A1 (20x objective lenses, 573 
acquisition software ZEN 2.6 (blue edition)) or a confocal laser scanning microscope LSM700 574 
(20x, 40x, 40x oil or 63x oil objective lenses, acquisition software ZEN 2012) at room 575 
temperature. NCAM and profilin2 immunofluorescence intensity was quantified by Image J. 576 
Identical telencephalon cortical regions from littermates of control and NCAM cKO mice (five 577 
sections per brain) were analyzed. NCAM/profilin2 immunofluorescence intensity was 578 
calculated as NCAM/profilin2 immunofluorescence intensity in different cortical regions in 579 
relation to the whole dorsal cortices. The average fluorescence density of NCAM/profilin2 was 580 
obtained by calculating the fluorescence density within a 250 μm2 area in different cortical 581 
layers. Cortical cells were counted in regions as described previously (Cappello et al., 2006; 582 
Seuntjens et al., 2009). In brief, Tbr1+ and ctip2+ cells were counted in the medial brain as they 583 
distribute evenly in layer VI and V of the dorsal cortex; Cux1+ and Olig2+ cells in the lateral 584 
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brain regions where they appear first; and GFAP+ cells in the dorsal pallium adjacent to the VZ 585 
where they reside. The total GFAP+ intensity was counted in VZ/SVZ because there are few 586 
GFAP+ cells appearing in the wild type at E16, and the earlier appearing GFAP+ cells do not 587 
distribute evenly in the VZ/SVZ (Fig. S5). Proliferating (i.e., BrdU+, Ki67+, PH3+), Tbr2+, 588 
Pax6+, Tbr1+, and Ctip2+ cells were counted in 100 µm x 250 µm areas in the dorsal pallium 589 
perpendicular to the VZ (red rectangle), and numbers of Cux1+ and Olig2+ cells were counted 590 
in 100 µm x 250 µm areas of the dorsolateral pallium (blue rectangle). Numbers of caspase3+ 591 
cells were determined in the entire hemi-telencephalon cortex. The GFAP expression per unit 592 
area (150 µm x 150 µm) was measured in the dorsolateral pallium adjacent to VZ using ImageJ 593 
(purple square).  594 
For cortical neuron distribution analysis, the maximum migration of neonatal cortical 595 
neurons was measured as the vertical distance from VZ to the destination of different layers 596 
using ImageJ. The length of the entire cortical layers perpendicular to the VZ was measured 597 
using ImageJ and defined as total cortical length. The distribution of layer-specific marker+ 598 
(Tbr1+, Ctip2+ or Cux1+) neuron was quantified by calculating maximum migration distance of 599 
each type of neurons/total cortical length (shown by schematic diagram in Fig. S3).  600 
 601 
Yeast two-hybrid screening 602 
Yeast two-hybrid screening was performed with the ProQuest Two-Hybrid system 603 
(Invitrogen, 10835) in Saccharomyces cerevisiae strain MaV203 following the manufacturer’s 604 
protocol. The DNA fragment encoding the intracellular domain of mouse NCAM140 was used 605 
as bait. 606 
 607 
Co-immunoprecipitation 608 
Lysates of brains from newborn C57BL/6J mice were prepared using ice-cold lysis buffer 609 
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(10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 1% sodium deoxycholate, 0.5% 610 
SDS, 2 mM EDTA, and protease inhibitor cocktail (Roche, 11697498001)). Lysates were 611 
centrifuged for 10 min at 15,000 g and 4°C, cleared with protein A/G-agarose beads (Santa 612 
Cruz Biotechnology, sc-2003, RRID: AB_10201400), and incubated with corresponding 613 
antibodies or, for negative control, non-immune IgG at 4°C overnight. Antibody/protein 614 
complexes were collected by incubating lysates with protein A/G-agarose beads for 3 h at 4°C, 615 
pelleting the beads and washing in PBS. Proteins were eluted with 2x SDS sample buffer by 616 
boiling the beads for 10 min and subjected to Western blot analysis. 617 
 618 
Quantitative real-time PCR 619 
Total RNA was extracted from cultured NPCs using Trizol Reagent (Invitrogen, 620 
15596018). Reverse transcription reactions were performed with the EasyScript® One-Step 621 
gDNA Removal and cDNA Synthesis SuperMix kits (Transgen Biotech, AE311-02). PCR 622 
primers were: forward 5′-GCCTATACGTTGATGGTGACTG-3′, reverse 5′-623 
ACAAAGACCAAGACTCTCCCG-3′ for profilin2, forward 5′-624 
GACAGAACCCGAAAAGGGC-3′, reverse 5′-GTTGGGGACCGTCTTGACTT-3′ for 625 
NCAM, forward 5′-AGGTCGGTGTGAACGGATTTG-3′, reverse 5′- 626 
TGTAGACCATGTAGTTGAGGTCA-3′ for GAPDH. The reaction procedure was conducted 627 
at 94°C, 15 min (1 cycle); 95°C, 30 s; 55°C, 30 s; 72 °C, 60 s (30 cycles), and 72°C, 8 min (1 628 
cycle). 629 
 630 
Immunocytochemistry and image analysis 631 
Immunocytochemistry was performed as described elsewhere (Ma et al., 2008). Briefly, 632 
cells were fixed in 4% paraformaldehyde in PBS for 15 min, permeabilized by 0.1% Triton X-633 
100 in PBS for 5 min, and blocked by 10% donkey serum in 0.1% Triton X-100 in PBS for 1 h 634 
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at room temperature. Cells were incubated with appropriate dilutions of primary antibodies in 635 
the blocking solution at 4°C overnight. Cells were then rinsed with PBS, and incubated with 636 
corresponding secondary antibodies in the blocking solution for 1 h at room temperature. The 637 
culture was rinsed three times with PBS, and counterstained with DAPI Fluoromount-G 638 
(Southern Biotech, 0100-20). To detect BrdU in cultured NPCs, cells were treated with 2 N HCl 639 
for 10 min at 37°C. The proportion of proliferating NPCs was quantified as the numbers of 640 
BrdU+ cells divided by the total number of DAPI+ cells. To estimate differentiation into 641 
neurons, astrocytes and oligodendrocytes, numbers of Tuj1+, GFAP+ or O4+ cells, respectively, 642 
were divided by the total number of DAPI+ cells. Proliferation and differentiation of profilin2 643 
siRNA-transfected NPCs were quantified from random images of areas containing cultured 644 
cells. The proportion of target cells was quantified as the numbers of BrdU+, Tuj1+, GFAP+ or 645 
O4+ cells divided by the total number of DAPI+ cells in the same field. Proliferation and 646 
differentiation of NPCs transfected with plasmids encoding profilin2, NCAM and mutNCAM 647 
were quantified from images of areas captured from top-to-bottom and left-to-right across the 648 
entire coverslip. The proportion of target cells was quantified as the numbers of BrdU+GFP+, 649 
Tuj1+GFP+, GFAP+GFP+ cells divided by the total number of GFP+ cells in the same coverslip. 650 
Each experiment was performed in independent triplicates.  651 
 652 
F-actin and G-actin analysis 653 
F- and G-actin levels were analyzed by Western blot using an F-actin/G-actin in vivo assay 654 
kit (Cytoskeleton, BK037). Briefly, cultured NPCs were lysed with pre-warmed F-actin 655 
stabilization buffer (50 mM PIPES buffer, pH 6.9, 50 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 656 
5% (v/v) glycerol, 0.1% Nonidet P40, 0.1% Triton X-100, 0.1% Tween 20, 0.1% β-mercapto-657 
ethanol) at 37°C for 10 min. Samples were centrifuged at 100,000 g for 1 h at 37°C. 658 
Supernatants containing G-actin were separated from the pellets containing F-actin and placed 659 
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on ice. The pellets were resuspended in the same volume as the supernatants using ice-cold 660 
water containing 1 μM cytochalasin D and incubated on ice for 1 h by pipetting up and down 661 
every 15 min to dissociate F-actin. Equal amounts of protein from each sample were subjected 662 
to Western blot analysis with anti-actin antibody with γ-tubulin serving as a control.  663 
To analyze levels of G- and F-actin by microscopy, NPCs were co-stained by phalloidin 664 
(for F-actin) and deoxyribonuclease I (for G-actin). GFP-positive cells were outlined, the F-665 
actin and G-actin labelling intensities were measured by Image Pro-plus 6.4 software (Media 666 
Cybernetics), and the ratio of F-actin/G-actin was calculated.  667 
 668 
CSI analysis 669 
The CSI analysis was performed as described elsewhere (Thakar et al., 2009). The coronal 670 
cortical sections at E12 were immunostained for actin with DAPI counterstaining to visualize 671 
cells and chromatin. Mitotic NPCs at metaphase and anaphase were identified by chromosome 672 
morphology at the VZ surface, selected, and analyzed (Haydar et al., 2003; Luxenburg et al., 673 
2011). Cell boundaries were outlined with ImageJ. Cell area and perimeter were determined, 674 
and the CSI was calculated as follows: CSI = 4π·area/(perimeter)2. The CSI assumes values 675 
between 1 (circular shape) and 0 (elongated, linear morphology) (Thakar et al., 2009). 676 
 677 
Statistical analysis 678 
Data were collected from at least three independent experiments (n≥3) or at least three 679 
pairs of NCAM cKO mice and control littermates (n≥3, five slices from each animal). Values 680 
are presented as means±SEM. Data distribution was checked by Kolmogorov-Smirnov test. 681 
Statistical difference was tested by Student’s t test, one-way ANOVA, or two-way ANOVA (for 682 
normal distribution data), Mann-Whitney or Kruskal-Wallis test (for non-normally distributed 683 
data) with appropriate post-hoc analysis using SPSS 22.0 software (all two-sided). P<0.05 was 684 
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considered statistically significant (*P<0.05, **P<0.01, ***P<0.001). 685 
 686 
Online supplemental material  687 
Fig. S1. Expression of NCAM and profilin2 in the developing cerebral cortex.  688 
Fig. S2. NCAM deficiency does not lead to increased NPC apoptosis during embryonic 689 
development.  690 
Fig. S3. NCAM deficiency does not affect the distribution of neonatal cortical neurons in the 691 
coronal plane.  692 
Fig. S4. Profilin2 expression is downregulated specifically by profilin2 RNA interference.   693 
Fig. S5. Schematic diagram showing areas chosen for quantification of cells in imaging 694 
analysis.  695 
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Figure legends 941 
 942 
Figure 1. NCAM is dynamically expressed in NPCs during cortical development.  943 
A, B: Coronal sections of mouse cortices from indicated embryonic stages were co-944 
immunostained for NCAM and Sox2 (A) or Tuj1 (B). Scale bars: 50 µm. C: Percentages of 945 
NCAM+ immunoreactivity in each layer. D: Average immunofluorescence density of NCAM 946 
in each layer. n=9 brain slices from 3 mice. Values represent mean±SEM. *P<0.05, **P<0.01; 947 
***P<0.001 (two-sided). One-way ANOVA with Bonferroni corrections (C (IZ, CP and MZ) 948 
and D (MZ)), Dunnett’s T3 correction (C (VZ/SVZ)), Kruskal-Wallis test with Dunn-949 
Bonferroni correction (D (VZ/SVZ, IZ, and CP)). VZ/SVZ, ventricular zone/subventricular 950 
zone. PP, preplate. IZ, intermediate zone. CP, cortical plate. MZ, marginal zone. 951 
 952 
Figure 2. NCAM deficiency transiently suppresses NPC proliferation in vivo.  953 
A: Coronal sections of control and NCAM cKO cortices were co-immunostained for BrdU and 954 
Pax6 30 min after BrdU injection. B-D: Numbers of Pax6+ (B), BrdU+ (C) cells, and 955 
percentages of Pax6+BrdU+ cells in total Pax6+ cell population (D). E-J: Coronal sections of 956 
control and NCAM cKO cortices were immunostained for Tbr2 (E), Ki67 (G) or PH3 (I) with 957 
DAPI counterstaining. Numbers of Tbr2+ (F), Ki67+ (H), and PH3+ (J) cells in the VZ/SVZ. K: 958 
Coronal sections of E14 control and NCAM cKO cortices were co-immunostained for BrdU 959 
and Ki67. L, M: Percentages of BrdU+Ki67- cells in the total BrdU+ cell population (L) and 960 
percentages of BrdU+Ki67+ cells in the total Ki67+ cell population (M). Scale bars: 50 µm. n=15 961 
brain slices from 3 mice. Values represent mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-962 
sided). Student’s t test or Mann-Whitney test (B (E12), C (E12), and F (E14)).  963 
 964 
Figure 3. NCAM deficiency reduces numbers of cortical neurons at early, but not later 965 
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developmental stages.  966 
A-C: Coronal sections of control and NCAM cKO cortices were immunostained for Tbr1 (A), 967 
Ctip2 (B), and Cux1 (C) with DAPI counterstaining. Scale bars: 50 µm. D-F: Numbers of Tbr1+ 968 
(D), Ctip2+ (E), and Cux1+ (F) cells per 2.5x104 µm2. n=15 brain slices from 3 mice. Values 969 
represent mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-sided). Student’s t test or Mann-970 
Whitney test (D(E14)).  971 
 972 
Figure 4. NCAM deficiency delays the generation of cortical neurons in vivo.  973 
A, B: Cortical sections of E18 control and NCAM cKO mice were co-immunostained for BrdU 974 
and Tbr1 (A) or Ctip2 (B). BrdU was injected at E11.5, E14.5 or E15.5. C: Cortical sections of 975 
P2 control and NCAM cKO mice were co-immunostained for BrdU and Cux1. BrdU was 976 
injected at E16.5. Scale bars: 50 µm. D-G: Percentages of BrdU+Tbr1+, BrdU+Ctip2+ or 977 
BrdU+Cux1+ cells in total populations of Tbr1+, Ctip2+, or Cux1+ cells after BrdU 978 
administration at E11.5 (D), E14.5 (E), E14.5 (F) or E16.5 (G). n=15 brain slices from 3 mice. 979 
Values represent mean±SEM. *P<0.05, **P<0.01 (two-sided). Student’s t test or Mann-980 
Whitney test (E, F (BrdU+Ctip2+ cells)).  981 
 982 
Figure 5. NCAM deficiency results in precocious gliogenesis.  983 
A: Coronal sections of the VZ were immunostained for GFAP with DAPI counterstaining. B: 984 
Densities of GFAP+ cells in the dorsolateral VZ. C: Total intensity of GFAP labelling per E16 985 
VZ/SVZ. D: Coronal sections of the dorsolateral VZ of P2 control and NCAM cKO mice were 986 
co-immunostained for BrdU and GFAP. BrdU was injected at E16.5. E: Numbers of 987 
BrdU+GFAP+ per 2.0 x 104 µm2 in the dorsolateral VZ. F: Coronal cortical sections of E18 and 988 
P0 control and NCAM cKO mice were immunostained for Olig2 with DAPI counterstaining. 989 
G: Numbers of Olig2+ cells per 2.5 x 104 µm2. H: Percentages of BrdU+Olig2+ cells in the total 990 
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Olig2+ cell population. I: Coronal sections of the dorsal VZ of P2 control and NCAM cKO 991 
mice were co-immunostained for BrdU and Olig2. BrdU was injected at E16.5. J: Cortical 992 
sections of E16 control and NCAM cKO mice were immunostained for A2B5 with DAPI 993 
counterstaining. K: Densities of A2B5+ cells. L: Cortical sections of E14 control and NCAM 994 
cKO mice were immunostained for BLBP+ with DAPI counterstaining. M: Densities of BLBP+ 995 
cells. Scale bars: 50 µm. n=15 brain slices from 3 mice. Values represent mean±SEM. *P<0.05, 996 
**P<0.01, ***P<0.001 (two-sided). Student’s t test or Mann-Whitney test (C, H).  997 
 998 
Figure 6. Profilin2 is a novel binding partner of NCAM.  999 
A: Co-immunoprecipitation analysis of the interaction between NCAM and profilin2 using P0 1000 
mouse brain homogenates. B: ELISA analysis of the binding of NCAM140ICD or 1001 
NCAM180ICD to immobilized profilin2. C-E: ELISA analysis of the binding of biotinylated 1002 
NCAM140ICD-derived peptides (C), wildtype NCAM140 (aa745-753) peptide and its mutant 1003 
variants with 749LC750 mutated to 749AS750, or 748NL749 mutated to 748GA749 (D), wildtype 1004 
NCAM140ICD or mutNCAM140ICD (749LC750 to 749AS750 mutation, E), to immobilized 1005 
profilin2. n=3 biological replicates. F: Schematic diagram of amino acid mutations in 1006 
mutNCAM140ICD. G, H: Coronal sections of the VZ (G) and the cortex (H) of control mice 1007 
were co-immunostained for profilin2, NCAM and Sox2 (G) or Tuj1 (H). Scale bars: 50 µm. I: 1008 
Average profilin2 immunofluorescence density in each layer. J: Percentages of profilin2 1009 
immunoreactivity in each layer. n=9 brain slices from 3 mice. K, L: Western blot analysis of 1010 
levels of NCAM and profilin2 in cultured NPCs derived from E14 control and NCAM cKO 1011 
VZ/SVZ (K). The relative levels of profilin2 protein in NCAM cKO NPCs, with the profilin2 1012 
levels in control NPCs set to 100% (L), n=4 biological replicates. M: qPCR analysis of the 1013 
levels of profilin2 mRNA in cultured NPCs derived from E14 control and NCAM cKO brains. 1014 
Profilin2 mRNA levels in control NPCs were set to 100%, n=5 biological replicates. Values 1015 
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represent mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-sided). Two-way ANOVA (B-E); 1016 
One-way ANOVA with Bonferroni corrections (J (IZ, CP and MZ), Dunnett’s T3 correction (J 1017 
(VZ/SVZ)); Kruskal-Wallis test with Dunn-Bonferroni corrections (I); paired t test (L, M). 1018 
VZ/SVZ, ventricular zone/subventricular zone. PP, preplate. IZ, intermediate zone. CP, cortical 1019 
plate. MZ, marginal zone. 1020 
 1021 
Figure 7. NCAM enhances NPC proliferation and differentiation through profilin2.  1022 
A: Cultured NPCs transfected with siProfilin2 or scrambled siRNA (NC) were incubated with 1023 
NCAM antibodies and BrdU. Cells were immunostained for BrdU with DAPI counterstaining. 1024 
B, E, F: Cultured NPCs transfected with siProfilin2 or NC were incubated with NCAM 1025 
antibodies or PBS and cultured in differentiation condition for 5 days. Cells were 1026 
immunostained for Tuj1 (B), GFAP (E) or O4 (F), and counterstained with DAPI. C, D, G, H: 1027 
Percentages of BrdU+DAPI+ (C), Tuj1+DAPI+ (D), GFAP+DAPI+ (G) and O4+DAPI+ (H) cells 1028 
in the total population of DAPI+ cells. I-K: Cultured NPCs cotransfected with profilin2 shRNA 1029 
(shProfilin2) and shProfilin2-resistant plasmids (Res Profilin2), shProfilin2 or control vector 1030 
expressing GFP alone (GFP) were incubated with NCAM antibodies or PBS and allowed to 1031 
differentiate for 3 days. Cells were immunostained for Tuj1 or GFAP. Percentages of Tuj1+GFP+ 1032 
(J), GFAP+GFP+ cells (K) in the total population of GFP+ cells. n=15 microscopic fields from 1033 
3 biological replicates. Scale bars: 50 µm (A, F, I) or 20 µm (B, E). Values represent 1034 
mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-sided); ns: not statistically significant. 1035 
Kruskal-Wallis test with Dunn-Bonferroni post hoc correction (C); One-way ANOVA with 1036 
Bonferroni corrections (D, G, J, K), or Dunnett’s T3 correction (H).  1037 
 1038 
Figure 8. NCAM enhances NPC proliferation and differentiation through profilin2-1039 
regulated actin dynamics. 1040 
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A: Western blot analysis of F-and G-actin levels in cultured control and NCAM cKO NPCs. γ-1041 
tubulin served as a control and was enriched in the F-actin fraction containing polymerized 1042 
tubulin. B: Relative levels of G- and F-actin in NCAM cKO NPCs. The levels of G- and F-actin 1043 
in control NPCs were set to 100%. n=4 biological replicates. C: Cultured MEFs were 1044 
cotransfected with NCAM siRNA (siNCAM) or scrambled siRNA (NC), and with lentiviruses 1045 
co-expressing GFP and wild type NCAM140 (NCAM) or mutant NCAM140 (mutNCAM). 1046 
MEFs cotransfected with NC and lentiviruses expressing GFP only served as control. Western 1047 
blot analysis of levels of NCAM, actin and tubulin. Lysis with the F-actin stabilization buffer 1048 
solubilizes and releases NCAM to the G-actin fraction. Relative levels of NCAM protein in the 1049 
G-actin fraction and the relative ratio of G- and F-actin were quantified. n=3 biological 1050 
replicates. D: Cultured NCAM cKO NPCs were transduced with lentiviruses co-expressing 1051 
GFP and NCAM or mutNCAM. NPCs transduced with lentiviruses expressing GFP only served 1052 
as control. NPCs were stained by fluorescent Phalloidin to visualize F-actin, and DNase I to 1053 
visualize G-actin. E, F: F-actin/G-actin ratios in cells are shown in D and G, respectively. n=54 1054 
cells (E), 21 cells (F) from 3 biological replicates. G: Cultured NCAM cKO NPCs were 1055 
transduced with plasmids co-encoding GFP, or profilin2 and GFP, stained with fluorescent 1056 
Phalloidin and DNase I. H: Coronal VZ sections of E12 control and NCAM cKO mice were 1057 
immunostained for actin with DAPI counterstaining. White dotted lines show examples of cell 1058 
boundaries. I: The CSI for dividing cells in the VZ. n=40 mitotic cells from 3 mice. J, K: 1059 
Cultured NCAM cKO NPCs were transduced with lentiviruses co-expressing GFP and NCAM 1060 
or mutNCAM, incubated with BrdU, and immunostained for BrdU with DAPI counterstaining 1061 
(J). Cultured NPCs differentiated for 5-7 days were immunostained for Tuj1, GFAP with DAPI 1062 
counterstaining (K). L-N: Percentages of BrdU+GFP+ (L), Tuj1+GFP+ (M) and GFAP+GFP+ (N) 1063 
cells in total GFP+ cell population. n=32 microscope fields from 3 biological replicates (L). n=5 1064 
biological replicates (M and N). Scale bars: 20 µm (D, G, J, K) or 5 µm (H). Values represent 1065 
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mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-sided); ns: not statistically significant. 1066 
Paired t test (B); Mann-Whitney test (I); one-way ANOVA with Dunnett’s T3 correction (C) or 1067 
Bonferroni corrections (M, N). Kruskal-Wallis test with Dunn-Bonferroni post hoc 1068 
comparisons (E, F, and L).  1069 
 1070 
Figure 9. The role of NCAM in regulating the temporal generation of neurons and glia in 1071 
the developing cortex. 1072 
A: NCAM expression is high in NPCs at the neurogenic period and declines at the gliogenic 1073 
period. The intracellular domain of NCAM interacts with profilin2 and promotes actin 1074 
polymerization in NPCs. NCAM-dependent actin regulation is required for rounding of NPCs 1075 
during mitosis as well as control of NPC proliferation and temporal differentiation into cortical 1076 
neurons and glia. B: Ablation of NCAM expression in NPCs results in reduced expression of 1077 
profilin2 and loss of its NCAM-dependent regulation, leading to decreased actin polymerization 1078 
and reduced rounding of mitotic NPCs. This slows down cell cycle progression, reduces NPC 1079 
proliferation at early stage of neural development, delays production of cortical neurons, and 1080 
leads to precocious formation of cortical glia.  1081 
1082 
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Supplementary Information 1083 
 1084 
Supplementary figure legends 1085 
  1086 
Figure S1. Expression of NCAM and profilin2 in the developing cerebral cortex.   1087 
A-G: Western blot analysis of NCAM and profilin2 expression in E12, E14, E16, E18, and P0 1088 
mouse cortices. γ-tubulin served as a control. The protein levels in E14, E16, E18, and P0 mouse 1089 
cortices were quantified relative to the protein levels in E12 mouse cortices set to 1.0. n=3 or 4 1090 
biological replicates (total NCAM and profilin2, respectively). H: Coronal sections of control 1091 
and NCAM cKO mouse cortices were co-immunostained for NCAM and Sox2 at E12 and E14. 1092 
Scale bars: 20 μm. Values represent mean±SEM. *P<0.05, **P<0.01, ***P<0.001 (two-sided). 1093 
One-way ANOVA with LSD corrections (C, F), with Dunnett’s T3 correction (B, D, and E) or 1094 
Kruskal-Wallis test with Dunn-Bonferroni post hoc comparisons (G). 1095 
 1096 
Figure S2. NCAM deficiency does not lead to increased NPC apoptosis during 1097 
embryonic development.  1098 
A: Coronal sections of E12, E14 and E16 control and NCAM cKO cortices were 1099 
immunostained for activated, cleaved caspase3 and counterstained with DAPI. B: Numbers of 1100 
caspase3+ cells in the entire hemi-telencephalon cortex. Mean±SEM values (n=15 brain slices 1101 
from 3 mice). Mann-Whitney test did not reveal statistically significant differences between 1102 
groups. Scale bars: 50 µm. VZ/SVZ, ventricular zone/subventricular zone. 1103 
 1104 
Figure S3. NCAM deficiency does not affect the distribution of neonatal cortical neurons 1105 
in the coronal plane.  1106 
A: The cortical neuron distribution was analyzed by the maximum migration distance of deep- 1107 
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(red arrow), or upper- (blue arrow) layer neurons from ventricular zone to cortical surface/total 1108 
cortical length (purple arrow). B-D: Percentages of the maximum migration distance of Tbr1+ 1109 
(B), Ctip2+ (C) and Cux1+ (D) neurons in total cortical length. Mean±SEM values (n=15 brain 1110 
slices from 3 mice). Student’s t test or Mann-Whitney test (B (E12, E14) and D (E18)). 1111 
 1112 
Figure S4. Profilin2 expression is downregulated specifically by profilin2 RNA 1113 
interference. 1114 
A: Western blot analysis of profilin2 levels in Neuro-2a cells transfected with either profilin2 1115 
siRNA (siProfilin2) or scrambled siRNA (NC). B: Levels of profilin2 in siProfilin2-transfected 1116 
cells relative to those in NC-transfected cells which were set to 1.0. C, D: qPCR analysis of the 1117 
levels of profilin2 (C) or profilin1 (D) mRNA in cultured NPCs transfected with either profilin2 1118 
siRNA (399, 527) or NC. The mRNA levels of profilin2/1 in NC-transfected NPCs were set to 1119 
1.0. E, F: Western blot analysis of profilin2 levels in Neuro-2a cells transfected with scrambled 1120 
shRNA (GFP), profilin2 shRNA (shProfilin2) only, or cotransfected with shProfilin2 and 1121 
shRNA-resistant profilin2 (Res Profilin2). The levels of profilin2 protein were quantified 1122 
relative to those in GFP-transfected cells set to 1.0. G: NCAM levels in brain homogenates 1123 
loaded in different quantities (26, 53 78, and 104 μg). Values represent mean±SEM. n=4 1124 
biological replicates. *P<0.05, **P<0.01 (two-sided); ns: not statistically significant. Paired t 1125 
test (B); one-way ANOVA with Dunnett’s T3 correction (C, D) or LSD corrections (F).  1126 
 1127 
Figure S5. Schematic diagram showing areas chosen for quantification of cells in 1128 
imaging analysis.  1129 
A: Red rectangle indicates the 100 µm x 250 µm area of interest in the DP perpendicular to the 1130 
VZ. Blue rectangle indicates the 100 µm x 250 µm areas of interest in the DP. Purple square 1131 
indicates the 150 µm x 150 µm areas of interest in DP adjacent to VZ. CM, cortical hem, MP, 1132 
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medial pallium, DP, dorsal pallium, LP, lateral pallium, and LV, lateral ventricle (see materials 1133 
and methods for details). B: Average immunofluorescence density of profilin2 in each cortical 1134 
layer. n=9 brain slices from 3 mice. Values represent mean±SEM. *P<0.05 (two-sided). 1135 
Kruskal-Wallis test with Dunn-Bonferroni post hoc test (CP); one-way ANOVA with 1136 
Bonferroni corrections (IZ and MZ). IZ, intermediate zone; CP, cortical plate; MZ, marginal 1137 
zone. 1138 
